Page 2 - Cancer Annual Congress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer

Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Oncology departmentBreast cancer annual congressMontpellier cancer instituteCancer annual congressMedical oncology department

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Jeff boyleKathleen murphyPfizer incArvinas incBreast cancer annual congressExchange commissionDrug administrationEuropean society for medical oncologyMedical oncologyMetastatic breastAbstract numberCancer annual congressFast trackDiscovery enginePrivate securities litigation reform actArvina annual report

Arvinas Announces Upcoming Vepdegestrant Poster

Arvinas Announces Upcoming Vepdegestrant Poster
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Jeff boyleKathleen murphyArvinas incExchange commissionBreast cancer annual congressPfizer incEuropean society for medical oncologyDrug administrationMedical oncologyMetastatic breastAbstract numberCancer annual congressFast trackDiscovery enginePrivate securities litigation reform actArvina annual report

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Jeff boyleKathleen murphyExchange commissionArvinas incEuropean society for medical oncologyDrug administrationPfizer incBreast cancer annual congressMedical oncologyMetastatic breastAbstract numberCancer annual congressFast trackDiscovery enginePrivate securities litigation reform actArvina annual report

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress - Olema Pharmaceuticals (NASDAQ:OLMA)

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress - Olema Pharmaceuticals (NASDAQ:OLMA)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan franciscoGeoffrey mogilnerOlema pharmaceuticals incBreast cancer annual congressEuropean society for medical oncologyDrug administrationCompany investor webcastEuropean societyMedical oncologyCancer annual congressInvestor webcastFast trackMedia contactVice president